ÎÛÎÛ²ÝÝ®ÊÓƵ

Jonathan Spicer

Academic title(s): 

Associate professor

Program Director, Advanced Thoracic and Upper GI Surgical Oncology Fellowship

Medical Director, ÎÛÎÛ²ÝÝ®ÊÓƵ Thoracic Oncology Network

Director, Thoracic Oncology Biobank

Jonathan Spicer
Contact Information
Address: 

1650 CEdar Avenue L9.520
Montreal, Quebec
Canada H3G 1A4

Email address: 
jonathan.spicer [at] mcgill.ca
Division: 
Associate Members
Branch: 
Thoracic and Upper GI Surgery
Location: 
ÎÛÎÛ²ÝÝ®ÊÓƵ University Health Centre
Graduate supervision: 

CURRENTLY ACCEPTING GRADUATE STUDENTS

Biography: 

Dr. Jonathan Spicer is an associate professor of surgery at ÎÛÎÛ²ÝÝ®ÊÓƵ University, where he is the medical director of the ÎÛÎÛ²ÝÝ®ÊÓƵ University Health Center (MUHC) Thoracic Oncology Network. He chairs the ÎÛÎÛ²ÝÝ®ÊÓƵ regional thoracic oncology tumor board and is co-director of the MUHC thoracic oncology clinical trials unit. Dr. Spicer is a surgeon scientist leading a broad research program covering basic, translational and clinical research topics. He trained in general surgery at ÎÛÎÛ²ÝÝ®ÊÓƵ University and subsequently in cardiothoracic surgery at the University of Texas, MD Anderson Cancer Centre. On a basic science front, Dr. Spicer is recognized as a leader in our understanding of how neutrophils impact cancer progression, and in particular, on the role of neutrophil extracellular traps in cancer biology. On a clinical front, Dr. Spicer has developed one of the most active research programs in the area of neoadjuvant immunotherapy for operable lung cancer. He is an expert in surgical enhanced recovery protocols and his clinical practice is focused on minimal access techniques for pulmonary surgery and extended resections for thoracic malignancies. He is the program director for the ÎÛÎÛ²ÝÝ®ÊÓƵ Advanced Thoracic and Upper GI Surgical Oncology Fellowship. Dr. Spicer is the research chair for the Canadian Association of Thoracic Surgeons, director of the Canadian Cancer Trials Mesothelioma Working Group and sits on numerous steering committees for phase 2 and 3 international trials investigating the use of novel therapies prior to lung cancer resections.

Current research: 

Research Interests:

Ìý

1. Role of neutrophils during lung cancer from carcinogenesis to metastasis.

2. Immunotherapy for locally advanced lung cancer

3. Role of neutrophil extracellular traps in surgical patients

4. Neutrophil extracellular traps in COVID19

5. Role of neutrophil extracellular traps in radiation therapy resistance

Selected publications: 

Back to top